Solid composition and method for producing the same

A solid composition of acetaminophen, glycine, and licorice addresses the issue of insufficient hardness in existing compositions by achieving a hardness of 40 N or more, enhancing transportability and abrasion resistance.

JP2026047123APending Publication Date: 2026-03-13DAIICHI SANKYO HEALTHCARE
View PDF 3 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-06-24
Publication Date
2026-03-13

AI Technical Summary

Technical Problem

Existing solid compositions containing acetaminophen lack sufficient hardness, which is crucial for transportability and abrasion resistance.

Method used

A solid composition comprising acetaminophen, glycine, and licorice is developed, with a hardness of 40 N or more, achieved through a method involving the formation of granules containing these ingredients and subsequent tabletting.

Benefits of technology

The composition provides enhanced hardness and abrasion resistance, ensuring effective delivery of active ingredients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2026047123000001
    Figure 2026047123000001
  • Figure 2026047123000002
    Figure 2026047123000002
Patent Text Reader

Abstract

To provide a solid composition containing acetaminophen that has sufficient hardness. [Solution] A solid composition containing acetaminophen, glycine, and licorice.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention broadly relates to a solid composition containing acetaminophen, glycine, and licorice, and a method for producing the same and the like.

Background Art

[0002] Solid compositions such as tablets for oral administration disintegrate in the digestive tract, and then the active ingredients in the composition are absorbed into the body. From the viewpoints of transportability and abrasion resistance, it is extremely important in the formulation design that the solid composition has a hardness of a certain level or more.

[0003] Since there are active ingredients of pharmaceuticals that lower the hardness of solid compositions, techniques for improving the hardness of solid compositions have been studied.

[0004] For example, Patent Document 1 discloses a composition having excellent tablet hardness and disintegrability without including a shaping agent by containing a disintegrant component and microfibrous cellulose.

[0005] Patent Document 2 discloses a method for improving the hardness of a tablet obtained by tableting granules obtained by wet granulating a mixture containing a main drug and suppressing the delay of the disintegration time by blending crystalline cellulose in the granules.

[0006] Patent Document ③ discloses a solid preparation containing acetaminophen, glycine, and at least one selected from the group consisting of caffeine, ethenzamide, ibuprofen, allyl isopropyl acetyl urea, and bromovaleryl urea. Patent Document 3 discloses that such a solid preparation has sufficient hardness.

Prior Art Documents

[0007] [Patent Document 1] International Publication No. 2020 / 022053 [Patent Document 2] Japanese Patent Publication No. 2005-047861 [Patent Document 3] Japanese Patent Publication No. 2024-050466 [Overview of the project] [Problems that the invention aims to solve]

[0008] However, solid compositions containing acetaminophen are not suitable from the perspective of reducing hardness. There is still room for improvement. The present invention contains acetaminophen having sufficient hardness. The objective is to provide a solid composition. [Means for solving the problem]

[0009] The present inventors have developed a solid composition containing acetaminophen, glycine, and licorice. We discovered that the degree was sufficiently high, which led to the completion of this invention.

[0010] In other words, this embodiment includes the following aspects. [1] A solid composition containing acetaminophen, glycine, and licorice. [2] [1] contains granules containing acetaminophen, glycine, and licorice. A solid composition. [3] The solid composition according to [1] or [2], wherein the hardness of the solid composition is 40 N or more. [4] [1] to [ A method for producing the solid composition described in any one of [3]. [5] A step of forming a granule containing acetaminophen, glycine, and licorice; A step of tabletting the granule; A method for producing the solid composition according to [4], comprising: [Advantages of the Invention]

[0011] According to the present invention, a solid composition containing acetaminophen having sufficient hardness can be provided. able. [Embodiments for Carrying Out the Invention]

[0012] Hereinafter, embodiments of the present invention (hereinafter referred to as "the present embodiments") will be described, but the scope of the present invention is not construed as being limited to the following embodiments. In the present embodiments, the composition can contain each component alone or in combination of two or more. In this specification, "~" indicating a numerical range represents "above" and "below", and includes both end values. (Solid Composition) In a first aspect, a solid composition containing acetaminophen, glycine, and licorice is provided. The solid composition is specifically a solid pharmaceutical composition.

[0013] (Solid Composition) In a first aspect, a solid composition containing acetaminophen, glycine, and licorice is provided. The solid composition is specifically a solid pharmaceutical composition. Each component contained in the solid composition according to the present embodiment may be contained in the state of a pharmacologically acceptable salt, or may be contained as a complex with other components. "Pharmacologically acceptable salts" include, for example, salts with bases or acids acceptable as pharmaceuticals.

[0014] Each component contained in the solid composition according to the present embodiment may be contained in the state of a pharmacologically acceptable salt, or may be contained as a complex with other components. "Pharmacologically acceptable salts" include, for example, salts with bases or acids acceptable as pharmaceuticals. "Pharmacologically acceptable salts" include, for example, salts with bases or acids acceptable as pharmaceuticals. Non-limiting specific examples of pharmacologically acceptable salts include addition salts of inorganic acids (hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, phosphoric acid, etc.), organic acids (p-toluenesulfonic acid, methanesulfonic acid, etc.). Non-limiting specific examples of pharmacologically acceptable salts include addition salts of inorganic acids (hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, phosphoric acid, etc.), organic acids (p-toluenesulfonic acid, methanesulfonic acid, etc.). hydrogen acid, sulfuric acid, phosphoric acid, etc.), addition salts of organic acids (p-toluenesulfonic acid, methanesulfonic acid, etc.). Acids, oxalic acid, p-bromophenylsulfonic acid, carboxylic acids, succinic acid, citric acid, benzoate Addition salts of acetic acid (such as acetic acid), inorganic bases (ammonium hydroxide or alkali or alkali) Examples include addition salts of earth metal hydroxides, carbonates, bicarbonates, etc., and addition salts of amino acids. Pharmacologically acceptable salts may be hydrated or anhydrous.

[0015] In this embodiment, the solid composition contains acetaminophen, glycine, and Because it contains cinnamon, it has sufficient hardness.

[0016] The hardness of the solid composition in this embodiment is as defined in the "Tablet Hardness" section of the 18th edition of the Japanese Pharmacopoeia Reference Information. Measurement method <g6-4-180>This is hardness measured by the method described in "". More specifically This is obtained by using a 9φ, 10.8R punch and compressing it in a tablet press at a pressure of 1,000 kgf. The hardness may be measured in the form of a tablet. The volume of the tablet used when measuring hardness is particularly important. Although not limited to this, one tablet may be 300 mg. More specifically, the solid in this embodiment The hardness of the composition may be the hardness measured by the method described in the examples.

[0017] The hardness of the solid composition measured as described above is preferably 40 N or higher. It is more preferably 40-200N, and even more preferably 45-150N. It is more preferably 50-140N, and even more preferably 60-130N. More preferably, the temperature is 70 to 120 N.

[0018] The solid composition in this embodiment tends to be superior in terms of abrasion resistance and / or tablet thickness. .

[0019] The degree of abrasion of the solid composition in this embodiment is as described in the "Tablets" section of the 18th edition of the Japanese Pharmacopoeia Reference Information. Abrasion Test Method <g6-5-150>This is the degree of wear measured by the method described in "". Specifically, a 9φ, 10.8R punch is used to compress tablets in a tablet press at a pressure of 1,000 kgf. The above abrasion degree may be measured in the form of a tablet obtained by doing so. The dosage of the drug is not particularly limited, but it may be 300 mg per tablet. More specifically, in this implementation... The degree of abrasion of the solid composition in its state is the hardness measured by the method described in the examples. stomach.

[0020] The degree of abrasion of the solid composition measured as described above is preferably 0.40% or less. It is more preferable that it be 0.30% or less, and even more preferable that it be 0.20% or less. It seems so. The lower limit of the above degree of wear is not particularly limited; for example, the above degree of wear is 0% or more. That's fine.

[0021] In this embodiment, the tablet thickness of the solid composition varies depending on the tablet volume and compression conditions. For example, using a 9φ, 10.8R punch, tablets are obtained by pressing them in a tablet press at a pressure of 1,000 kgf. The tablet thickness, measured in the form of a 300mg tablet, may be 5.0mm or less. The dimensions may be between 2.0 and 5.0 mm, or between 3.0 and 4.5 mm.

[0022] (Acetaminophen) As used herein, "acetaminophen" refers to CAS Registry Number 103-90 It is a compound with the chemical formula C8H9NO2, and is a salt of acetaminophen. This is not particularly limited as long as it is pharmacologically acceptable.

[0023] The amount of acetaminophen included depends on the intended use of the solid composition and the desired degree of cough suppressant and expectorant effect. The required degree of hardness, the symptoms of the recipient, age, weight, sex, etc., are adjusted as appropriate. It will be restricted.

[0024] The amount of acetaminophen included is, for example, 1 per day for an adult. 20 mg to 1200 mg, preferably 150 mg to 900 mg, more preferably 180 mg The amount can be adjusted in the range of g to 600 mg. In this embodiment, "adult" means a male aged 15 or older. It means "woman." However, the solid composition according to this embodiment is not limited to being for adult consumption. It is not intended for use by children, and may be taken by children under 15 years of age. In such cases, the dosage should be reduced to 1 / 2 or 2 / 3 of the daily dose taken by adults, depending on the age group. This is possible. The same applies to ingredients other than acetaminophen.

[0025] The weight and dosage of the above solid composition are the daily dose (daily amount), but the same amount The substance can be administered to the target in one dose, or multiple times a day, for example, two or three times, preferably in three separate doses. It may be administered. The same applies to ingredients other than acetaminophen. Also, each dosage Since this is the total amount, the amount per dose and the dosage form of the solid composition will vary depending on the individual components contained in the solid composition. The content may vary.

[0026] In certain embodiments, the solid composition is a tablet, and the above dosage is 3 tablets, 6 tablets, or This is the amount of the ingredient contained in 9 tablets, preferably the amount of the ingredient in 9 tablets. For adults (15 years and older), the single dose is three times a day, with each dose consisting of 2 tablets, 3 tablets, or The dosage is 4 tablets, preferably 3 tablets per dose.

[0027] (glycine) As used herein, "glycine" refers to the glycine with CAS registry number 56-40-6. It is a compound represented by the chemical formula C2H5NO2. Glycine salts are pharmacologically acceptable. Therefore, it is not particularly limited.

[0028] The amount of glycine varies depending on the amount of acetaminophen, etc., but the amount per day is... For example, 10 mg to 1000 mg, preferably 30 mg to 950 mg, more preferably Or, in the range of 100 mg to 900 mg, more preferably in the range of 180 mg to 900 mg. It can be adjusted.

[0029] The mass ratio of acetaminophen to glycine contained in the composition administered daily (acetaminophen The aminophen:glycine ratio is preferably 4:1 to 1:3, and more preferably 3:1. The ratio is approximately 1:2, and more preferably 2:1 to 1:1.

[0030] (Licorice) As used herein, "licorice" refers to the term as it appears in the 18th edition of the Japanese Pharmacopoeia. This can be used. For licorice, for example, water or 30% ethanol can be used as the extraction solvent. Some products use aqueous solutions of licorice, such as licorice extract and dried licorice extract. Depending on the type of extract, such as licorice soft extract or licorice fluid extract, the crude drug equivalent ratio varies. Such products are sold. The quantities of licorice described herein are not specified unless otherwise noted. The values ​​are calculated based on the equivalent amount of crude drugs. For example, licorice extract is calculated per 1 part by mass of the extraction solvent. It contains approximately 4 parts by mass of licorice in terms of crude drug equivalent. In addition, the extract of these licorice In addition to the above, there is also a powdered extract made by extracting licorice with water or a 30% ethanol aqueous solution. (Extract powder), as well as licorice extract, licorice extract solution, etc. may be used as appropriate, and there is no particular limitation It is not fixed. However, the ratio is approximately 5 to 9 parts by mass of crude drug per 1 part by mass of extraction solvent. Parts by mass, for example, about 6 to about 8 parts by mass of licorice extract containing licorice, are dried. The extract powder is preferred. The extraction solvent is preferably water.

[0031] Furthermore, licorice is selected from the group consisting of glycyrrhizic acid and its salts as its main components. It contains at least one of the following. When used herein, "glycyrrhizic acid" is The CAS registry number is 1405-86-3, and C 42 H 62 O 16 Compounds represented by the chemical formula It is (molecular weight: 822.93 g / mol). Salts of glycyrrhizic acid are pharmacodynamically acceptable. It is not particularly limited as long as it is a substance, but for example, trisodium glycyrrhizinate, glycyrrhizinate Disodium glycyrrhizate, diammonium glycyrrhizinate, monoammonium glycyrrhizinate Examples include dipotassium glycyrrhizinate and monopotassium glycyrrhizinate.

[0032] Therefore, in the solid composition according to this embodiment, licorice is replaced with and / or added Furthermore, the mixture contains at least one selected from the group consisting of glycyrrhizic acid and its salts. It is also good. Licorice is composed of glycyrrhizic acid and its salts in the dried crude drug. It may contain at least 2.0% of one species selected from the group. Licorice powder is calculated as raw At least one selected from the group consisting of glycyrrhizic acid and its salts to the dried drug It may contain 2.0% or more of the following. Licorice extract is a group consisting of glycyrrhizic acid and its salts. It may contain at least 3.6% of one selected from the following. Licorice crude extract is glycyst It contains at least 4.8% of at least one substance selected from the group consisting of ruric acid and its salts. i. In the solid composition according to this embodiment, the total content of glycyrrhizic acid and its salts is The licorice content is, for example, 0.01 to 0.1 times (for example, 0.02 times) as described later. The range can be calculated by multiplying by 0.036, 0.04, and 0.048.

[0033] The extracted components are obtained by conventional methods, for example, by extracting the active ingredients from the crude drug using an extraction solvent. It can be obtained by the following. Examples of extraction solvents include water, hydrophilic solvents, or mixtures thereof. A solvent is often used. Examples of the hydrophilic solvent include methanol, ethanol, and prophosphate. Panol, Isopropanol, Butanol, Isobutanol, S-Butanol, T-Butanol Alcohols such as methyl cellosolve and ethyl cellosolve; cellosolves such as methyl cellosolve and ethyl cellosolve. Ketones such as acetone; ethers such as dioxane and tetrahydrofuran; pyrid N, Morpholine, Acetonitrile, N,N-dimethylformamide, Dimethylacetamide Examples include nitrogen-containing solvents such as N-methylpyrrolidone. These hydrophilic solvents are It may be used alone or as a mixture of two or more solvents.

[0034] The amount of licorice used depends on the intended use of the solid composition, the required degree of hardness, and the target of administration. The dosage is adjusted as appropriate according to symptoms, age, weight, sex, etc. The amount of licorice used is calculated based on the equivalent amount of crude drug. For example, 100mg to 5,000mg per day, preferably 200mg to 2,0 The amount is 00 mg, more preferably in the range of 50 mg to 1,200 mg.

[0035] The amount of licorice contained in the composition administered daily is 1% by mass to 7% in terms of crude drug equivalent. 0% by mass, preferably 5% to 50% by mass, more preferably 10% to 30% by mass be.

[0036] The mass ratio of acetaminophen to licorice in the composition administered daily is A Setoaminophen: In terms of the ratio of licorice to crude drug, preferably 1:10 to 2:1, Preferably, the ratio is 1:7 to 2:1, and more preferably 1:7 to 1:1. When using licorice extract powder, the mass ratio of acetaminophen to licorice extract powder is: Preferably 1:2 to 10:1, more preferably 1:2 to 7:1, and even more preferably 1:1 The ratio is approximately 7:1.

[0037] From the viewpoint of further increasing the hardness of the solid composition according to this embodiment, licorice is used. It is preferable that it be contained in the same granules as ethanol and / or glycine. The solid composition in form contains acetaminophen and / or glycine and licorice. Preferably containing granular material, and containing acetaminophen and / or glycine and licorice. It is preferable to include granules obtained by granulating the mixed powder. From a similar viewpoint, licorice is a It is preferable that cetoaminophen and glycine are included in the same granule. The solid composition according to this embodiment is a granular composition containing acetaminophen, glycine, and licorice. It is preferable to include the following, and a mixed powder containing acetaminophen, glycine, and licorice is prepared. It is preferable that the solid composition according to this embodiment contains granules obtained by granulation. The tablet may be obtained by compressing granules, which are a type of granulated material, into a tablet.

[0038] However, the solid composition according to this embodiment contains acetaminophen, glycine, and licorice. The tablets may be manufactured by a direct compression method in which a mixed powder containing acetaminophen is directly compressed into tablets. A powder obtained by dissolving fen, glycine, and licorice in a solvent and then drying off the solvent, and Alternatively, the powder may be optionally granulated and then compressed into tablets.

[0039] In this embodiment, acetaminophen, glycine, and licorice are used in the solid composition. As they are in close proximity, the hardness of the solid composition tends to improve further. .

[0040] (Other ingredients) The solid composition according to this embodiment may contain components other than those listed above, depending on its intended use. The solid composition relieves various cold symptoms, such as runny nose, nasal congestion, sneezing, sore throat, cough, and For the purpose of relieving chills, fever, headache, joint pain, muscle pain, etc., bromhexyl In addition to meloxicam, antipyretic analgesics, especially nonsteroidal anti-inflammatory drugs (NSAIDs) ) and other pharmacologically acceptable ingredients may be included.

[0041] Nonsteroidal anti-inflammatory drugs include ibuprofen, diclofenac, loxoprofen, and za Lutoprofen, pranoprofen, oxaprozin, tiaprofenic acid, naproxen , lornoxicam, ampiroxicam, piroxicam, nabumetone, indomethacin, s COX-2 nonselective inhibitors such as lindac, mofezolac, and mefenamic acid, and meloxicam. These are broadly classified into COX-2 selective inhibitors such as etodolac and celecoxib. Meloxicam is It may be incorporated into the composition as a nonsteroidal anti-inflammatory drug. Nonsteroidal anti-inflammatory drugs are C It is preferable that it be an OX-2 nonselective inhibitor. Nonsteroidal anti-inflammatory drugs are in the form of salts. That's fine.

[0042] Other pharmacologically acceptable ingredients include those found in combination cold medicines, antipyretic analgesics, and rhinitis medications. Antihistamines, antipyretics and analgesics, cough suppressants and expectorants, anti-inflammatory drugs, central nervous system stimulants, vitamins The drug may also be formulated with other agents such as anticholinergics and antiplasmins.

[0043] For example, antihistamines include isopendyl hydrochloride, difeterol hydrochloride, and triphosphate hydrochloride. Perenamin, tondiamine hydrochloride, phenetazine hydrochloride, methidilazine hydrochloride, dl-chlor Pheniramine maleate, d-chlorpheniramine maleate, diphenyl disulfone Carbinoxamine phosphate, diphenylpyraline hydrochloride, diphenylpyraline theoclate, Diphenhydramine hydrochloride, diphenhydramine salicylate, alimethazine tartrate, Diphenhydramine iodine, triprolidine hydrochloride hydrate, mebhydrolysine napadisylate N, promethazine methylene disalicylate, carbinoxamine maleate, diphosphate Examples include terol, clemastine fumarate, and mequitazine.

[0044] Examples of antipyretic analgesics other than nonsteroidal anti-inflammatory drugs include aspirin and ethenzame. D, salicylamide, lactylphenethidine, isopropylantipyrine, etc. These are some examples.

[0045] Cough suppressants and expectorants include noscapine, noscapine hydrochloride hydrate, and tipepidine hibenzate. Dextromethorphan hydrobromide hydrate, bromhexine, dihydrocodeine phosphate Salts, dl-methylephedrine hydrochloride, dl-methylephedrine saccharin salt, psyl Examples include idoephedrine hydrochloride, ambroxol hydrochloride, and L-carbocysteine. ru.

[0046] Anti-inflammatory drugs include glycyrrhizic acid and its derivatives and their salts (for example, glycyrrhizic acid and its derivatives and salts). Dipotassium lycyrrhizinate, monoammonium glycyrrhizate, etc., tranexamic acid, etc. These are some examples.

[0047] Examples of central nervous system stimulants include caffeine and anhydrous caffeine.

[0048] Vitamin supplements include vitamin B1 and its derivatives and their salts (e.g., Benf Othiamine, vitamin B2 and its derivatives and their salts (e.g., riboflavin) Vitamin C and its derivatives and their salts (e.g., ascorbic acid), hesperidin Examples include ions and their derivatives, as well as salts thereof.

[0049] Anticholinergic agents include scopolamine hydrobromide, datura extract, and methylscopolamine. Bromides, methyl-l-hyoscyamine bromide, pirenzepine hydrochloride, butylscopolamine Bromides, belladonna alkaloids, belladonna extract, total belladonna alkaloids, iodine Isopropamide, diphenylpiperidinomethyldioxolane iodide, belladonna extract, ro Examples include belladonna root, belladonna root total alkaloid citrate, etc.

[0050] The solid composition according to this embodiment may be further modified by adding a formulation additive as needed. Possible alternatives include pharmaceutically acceptable carriers, such as excipients, binders, and disintegrants. Disintegration aids, glossing agents, foaming agents, moisture-proofing agents, surfactants, stabilizers, antioxidants, fillers, Sweeteners, flavoring agents, cooling agents, fragrances, air fresheners, coloring agents, bases, coating agents, sugar coating agents, etc. Examples include plasticizers, dispersants, defoamers, fluidizers, and flavoring agents / fragrances, etc., as well as conventionally known solid formulations. Pharmaceutical additives that can be used for the above purposes may be used for the above purposes.

[0051] Excipients include, for example, sugar powder, gum arabic, powdered gum arabic, cocoa butter, caramel. Sodium carboxymethyl starch, hydrated silicon dioxide, anhydrous amorphous silicon dioxide, Xylitol, magnesium aluminosilicate, calcium silicate, magnesium silicate Light anhydrous silicic acid, crystalline cellulose, crystalline cellulose-carmellose sodium, crystalline cellulose Lurose (fine particles), crystalline cellulose (granules), powdered cellulose, synthetic aluminum silicate Synthetic aluminum silicate, hydroxypropyl starch, crystalline cellulose, wheat cellulose Pun, rice flour, rice starch, heavy anhydrous silicic acid, refined white sugar, refined white sugar spherical granules, gelatin, D-sorbitol, calcium carbonate, magnesium carbonate, precipitated calcium carbonate, low degree of substitution Hydroxypropylcellulose, dextrin, corn starch, corn Starch granules, trehalose, silicon dioxide, lactose monohydrate, lactose granules, sucrose, potato Sweet potato starch, hydroxypropyl starch, partially pregelatinized starch, powdered sugar, powdered candy, powdered syrup Original maltose syrup, powdered cellulose, pectin, polyoxyethylene hydrogenated castor oil, polio Xyethylene hydrogenated castor oil 60, maltitol, D-mannitol, aluminum metasilicate Examples include magnesium sulfate, calcium sulfate, erythritol, glucose, and fructose.

[0052] Examples of binders include gum arabic, gum arabic powder, kanbai flour, gelatin, and ceramic. Hydroxypropyl starch, hydroxypropyl cellulose, hypromellose, Lulan, povidone, polyvinyl alcohol (fully saponified), polyvinyl alcohol (partially saponified) (Diluted methacrylate), methacrylate copolymer L, methacrylate copolymer LD, methacrylate Copolymer S, butyl methacrylate / methyl methacrylate copolymer, methylcellulose Examples include polyvinyl alcohol-acrylic acid-methyl methacrylate copolymers.

[0053] Examples of disintegrants include sodium carboxymethyl starch, carmellose, and caramel. Mellose calcium, croscarmellose sodium, croscarmellose sodium, Crospovidone, low-substituted hydroxypropyl cellulose, hydroxypropyl starch Examples include partially pregelatinized starch.

[0054] Examples of disintegration aids include carboxymethyl starch sodium, carmellose, Carmellose calcium, croscarmellose sodium, light anhydrous silicic acid, crystalline cellulose Sodium bicarbonate, precipitated calcium carbonate, lactose monohydrate, hydroxypropyl starch -ch, polysorbate 40, polysorbate 60, polysorbate 80, macrogol 1 Examples include 500 and macrogol 4000.

[0055] Examples of glossing agents include carnauba wax, bleached beeswax, refined shellac, and macromolecules. Goal 400, Macro Goal 1500, Macro Goal 4000, Macro Goal 6000, Examples include macrogol 6000NF and beeswax.

[0056] Examples of foaming agents include anhydrous sodium carbonate, tartaric acid, potassium bitartrate, and carbonated water. Examples include sodium chloride and anhydrous citric acid.

[0057] Examples of moisture-proofing agents include ethylcellulose, olive oil, and dried aluminum hydroxide gel. Glycerin, magnesium silicate, light anhydrous silicic acid, hydrogenated oil, synthetic aluminum silicate sucrose fatty acid ester, stearic acid, magnesium stearate, refined shellac, Refined sugar, talc, neutral anhydrous sodium sulfate, precipitated calcium carbonate, fumaric acid, stearin Acid, polyvinyl acetal diethylaminoacetate, hydroxypropyl methylcellulose -2910 mixture, polyvinyl acetal diethylaminoacetate, aluminum metasilicate Examples include magnesium methyl phosphate.

[0058] Examples of surfactants include sucrose fatty acid esters and polyoxyethylene hydrogenated castor oil. Oil 20, polyoxyethylene hydrogenated castor oil 60, polyoxyethylene stearyl ether , polyoxyethylene cetyl ether, polyoxyethylene sorbitan monolaurate, Polyoxyethylene sorbitan beeswax, polyoxyethylene nonylphenyl ether, Polyoxyethylene (20) polyoxypropylene (20) glycol, polyoxyethylene Poly(105)polyoxypropylene(5)glycol, polyoxyethylene(120) Polyoxypropylene (40) glycol, polyoxyethylene (160) polyoxypropylene Polypropylene (30) glycol, polyoxyethylene (10) polyoxypropylene (4) Cetyl ether, polysorbate 20, polysorbate 60, polysorbate 80, macro Logol 400, sorbitan monooleate, glyceryl monostearate, monostearate Examples include sorbitan phosphate, sorbitan monolaurate, and sodium lauryl sulfate. ru.

[0059] Examples of stabilizers include adipic acid, L-aspartic acid, and L-aspartic acid sodium. Thorium, DL-alanine, L-alanine, L-arginine, L-arginine hydrochloride, A Sodium benzoate, propylene glycol alginate, benzoic acid, sodium benzoate Thorium, ethylenediamine, calcium disodium edetate, sodium edetate, Tetrasodium edetate, tetrasodium edetate tetrahydrate, zinc chloride, ammonium chloride, salt Calcium chloride hydrate, cetylpyridinium chloride, ferric chloride, sodium chloride, magnesium chloride Nesium, cysteine ​​hydrochloride, L-histidine hydrochloride, cocoa butter, carboxyvinyl polymer , carmellose calcium, hydrated silicon dioxide, carmellose sodium, dried sodium carbonate Glycerin, glycerin, glycerin fatty acid ester, calcium gluconate hydrate, gluconate Sodium glutamate, magnesium gluconate, potassium L-glutamate, L-glutamine Sodium phosphate, L-lysine glutamate, light anhydrous silicic acid, crystalline sodium dihydrogen phosphate Um, chondroitin sulfate sodium, zinc oxide, L-cystine, L-cysteine, tartaric acid Acid, sucrose fatty acid ester, stearic acid, refined gelatin, refined soy lecithin, gelatin Gelatin hydrolysate, sorbitan fatty acid ester, taurine, talc, calcium carbonate Potassium bicarbonate, sodium bicarbonate, sodium carbonate hydrate, magnesium carbonate, Natural vitamin E, tocopherol, tocopherol acetate, lactose, concentrated glycerin, Povidone, polyoxyethylene hydrogenated castor oil 60, polyoxyethylene stearyl ether L, polyoxyethylene cetyl ether, polyoxyethylene nonylphenyl ether, Polyoxyethylene hydrogenated castor oil, polyoxyethylene (42) polyoxypropylene ( 67) Glycol, polyoxyethylene (54) polyoxypropylene (39) glyco Polyoxyethylene (160) polyoxypropylene (30) glycol, polyoxy Polyethylene (196) polyoxypropylene (67) glycol, polyoxyethylene Glyceryl oats (7E.O.), polysorbate 20, polysorbate 60, poly Sorbate 80, polyvinyl alcohol (partially saponified), macrogol 300, macro Gol 400, Macrogol 4000, Anhydrous Citric Acid, Anhydrous Sodium Citrate, Anhydrous Li Sodium monohydrogen phosphate, anhydrous sodium dihydrogen phosphate, magnesium aluminometasilicate Methylcellulose, l-menthol, glyceryl monostearate, medicinal charcoal, magnesium sulfate Gnesium hydrate, DL-malic acid, sodium hydrogen phosphate hydrate, potassium dihydrogen phosphate M, calcium dihydrogen phosphate hydrate, L-leucine, polyvinyl alcohol, acrylic acid Examples include methyl methacrylate copolymers.

[0060] Examples of antioxidants include ascorbic acid, L-ascorbic acid, and steate. Ingredients: Citric acid hydrate, soy lecithin, natural vitamin E, tocopherol tocopherol acetate, ascorbic acid palmitate, sodium pyrosulfite, etc. Examples include: In the case of a solid composition containing acetaminophen, an antioxidant or stabilizer. It is preferable not to include tocopherols.

[0061] Examples of fillers include RSS No. 1 raw rubber, starch acrylate 1000, and Examples include silicon dioxide, titanium dioxide, silicon dioxide, and calcium monohydrogen phosphate.

[0062] Examples of sweeteners include aspartame, acesulfame potassium, amacha, and ama. Tea powder, reduced maltose syrup, xylitol, dipotassium glycyrrhizinate, glycyrrhizin Disodium saccharin, saccharin sodium hydrate, sucralose, stevia Stevia extract, refined stevia extract, refined sucrose, fructose, sucrose, maltitol, D-mannitol Examples include erythritol.

[0063] Examples of flavoring agents include sodium chloride, Phellodendron bark powder, Parmesan extract, Coptis japonica, and others. Uren powder, orange, orange oil, cocoa powder, fructose, caramel, xylitol, citric acid Calcium, citric acid hydrate, sodium citrate hydrate, L-glutamic acid, L-glutamic acid Sodium thamate, grapefruit extract, brown sugar, cinnamon powder, cinnamon oil, saccharin Ingredients: Sodium saccharin hydrate, Japanese pepper powder, tartaric acid, D-tartaric acid, potassium bitartrate. Um, DL-sodium tartrate, ginger powder, sucralose, stevia extract, ste Via extract refined product, Swertia japonica, D-sorbitol, tannic acid, clove oil, citrus peel tincture Chili pepper, chili pepper powder, spruce powder, trehalose hydrate, porcini powder, plum extract, Fructooligosaccharides, powdered sugar, peppermint powder, D-mannitol, dl-menthol l-menthol, menthol powder, dragon's mane, dragon's mane powder, green tea powder, DL- Examples include ngolic acid, DL-sodium malate, lemon oil, and rose oil.

[0064] Examples of cooling agents include fennel oil, d-camphor, dl-camphor, and cinnamon oil. Examples include peppermint water, peppermint oil, and l-menthol.

[0065] Flavorings include, for example, orange flavor, guarana extract, sweet orange, and Strawberry, brown sugar flavor, strawberry flavor, cherry flavor, banana powder Dark flavor, peach essence, fruit essence, peppermint, melon powder Examples include flavorings, l-menthol, and peppermint oil.

[0066] Examples of fragrances include fennel powder, fennel oil, ethyl vanillin, and d-camphor. dl-camphor, cinnamon powder, cinnamon oil, ginger oil, agarwood powder, spearmint Oil, clove oil, turpentine oil, chili pepper powder, pineapple powder, flavoring 51357, pineapple Apple powder flavoring 59492, peppermint water, peppermint oil, vanilla powder flavoring 54286, vanillin Bergamot oil, d-borneol, dl-borneol, dl-menthol, l- Examples include ethanol, eucalyptus oil, rose water, and rose oil.

[0067] Examples of coloring agents include yellow iron oxide, yellow iron(III) oxide, orange essence, and brown iron oxide. Iron, carbon black, caramel, beta-carotene, gold leaf, black iron oxide, titanium dioxide, tri-dioxide Iron compounds, dizuazo yellow, food blue No. 1, food yellow No. 4, food yellow No. 5, food blue No. 2 Aluminum lake, Food Yellow No. 4, Aluminum lake, Food Red No. 2, Food Red No. 3, Food Red No. 102, iron(III) oxide / glycerin suspension, copper chlorophyllin sodium, copper chlorophyllin Lofil, phenol red, malachite green, methylene blue, medicinal charcoal, riboflavin Bottle, riboflavin butyrate, riboflavin sodium phosphate, green tea powder, ro Examples include oils and other similar substances.

[0068] The base ingredients are acacia powder, pregelatinized starch, ethylcellulose, and cocoa butter. Carnauba wax, carboxyvinyl polymer, carmellose, carmellose sodium Reduced maltose syrup, hydrated silicon dioxide, dried aluminum hydroxide gel, agar, can Marbled powder, xanthan gum, glycerin, glycerin fatty acid ester, light anhydrous silicic acid, knot Crystalline cellulose, hydrogenated oil, synthetic aluminum silicate, synthetic magnesium sodium silicate, Titanium dioxide, tartaric acid, sucrose fatty acid ester, silicone oil, stearic acid, stearic acid Magnesium, gelatin, D-sorbitol, talc, calcium carbonate, corn Pumps, lactic acid, ethyl lactate, calcium lactate hydrate, lactic acid / glycolic acid copolymer, concentrated Lycerin, potato starch, hydroxypropylcellulose, hypromellose, plutonium Lan, pectin, povidone, polysorbate 60, polysorbate 80, polyvinyl alcohol Coal (partially saponified), microcrystalline wax, macrogol 200, macro Goal 300, Macro Goal 400, Macro Goal 1000, Macro Goal 1500, Ma Crogol 1540, Macrogol 4000, Macrogol 6000, Macrogol 60 00NF, Macrogol 20000, D-mannitol, Glyceryl monostearate, Sorbitan monostearate, batyl monostearate, propylene monostearate Recall, polyethylene glycol monostearate, sodium lauryl sulfate, polyvinyl sulfate Examples include a copolymer of methyl methacrylate, acrylic acid, and methyl alcohol.

[0069] Examples of coating agents include ethyl acrylate / methyl methacrylate copolymer. Dispersion, aminoalkyl methacrylate copolymer E, aminoalkyl methacrylate Polymer RS, gum arabic, gum arabic powder, ethylcellulose, ethylcellulose water Dispersion, carnauba wax, carboxyvinyl polymer, gold leaf, silver leaf, triethyl citrate Glycerin, glycerin fatty acid ester, hydrogenated oil, titanium dioxide, sucrose fatty acid ester , stearyl alcohol, stearic acid, magnesium stearate, refined gelatin, Shellac, gelatin, D-sorbitol, talc, calcium carbonate, magnesium carbonate Gold leaf, precipitated calcium carbonate, concentrated glycerin, white shellac, hydroxypropyl cellulose Rose, hydroxypropyl methylcellulose acetate succinate, hydroxypropyl Pyrmethylcellulose 2910, titanium dioxide, macrogol 400 mixture, hypromellol S, fumaric acid, stearic acid, polyvinyl acetal diethylaminoacetate, hydro Xypropylmethylcellulose 2910 mixture, pullulan, polysorbate 80, polypropylmethylcellulose Nylacetal diethylaminoacetate, povidone, polyvinyl alcohol (partially hydrated) (Monster), Macrogol 300, Macrogol 400, Macrogol 600, Macrogol 1500, Macrogol 1540, Macrogol 4000, Macrogol 6000, Mac Logol 6000NF, Macrogol 20000, Macrogol 35000, Methacrylic Acid copolymer L, methacrylic acid copolymer LD, methacrylic acid copolymer S, metasilicic acid Magnesium aluminate, methyl acrylate, methacrylic acid, methyl methacrylate Tocopolymer, methylcellulose, 2-methyl-5-vinylpyridine methyl acrylate • Methacrylic acid copolymer, aluminum monostearate, glyceryl monostearate N, sorbitan monostearate, sorbitan monolaurate, calcium sulfate, polyvinyl sulfate Examples include a copolymer of methyl methacrylate, acrylic acid, and methyl alcohol.

[0070] Examples of sugar coating agents include gum arabic, gum arabic powder, ethylcellulose, and carnauba. Uva wax, carboxymethylcellulose sodium, titanium dioxide, stearic acid, polyoxy stearate Sil-40, refined gelatin, refined shellac, refined white sugar, gelatin, shellac, talc, precipitate Calcium carbonate, white shellac, sucrose, hydroxypropylcellulose, hypromellose Pullulan, povidone, polyvinyl alcohol (partially saponified), macrogol 1500 Macrogol 4000, Macrogol 6000, Macrogol 6000NF, Hydrophosphate Calcium hydrate, calcium dihydrogen phosphate hydrate, polyvinyl alcohol, acrylic Examples include acid-methyl methacrylate copolymers.

[0071] Examples of plasticizers include triethyl citrate, glycerin, and glycerin fatty acid ester. Lu, D-sorbitol, medium-chain triglyceride, triacetin, concentrated glycerin, castor oil Castor oil, polyoxyethylene hydrogenated castor oil 60, propylene glycol, polyoxyethylene (105) Polyoxypropylene (5) Glycol, Polysorbate 80, Macroglucose Lu 400, Macrogol 600, Macrogol 1500, Macrogol 4000, Macro Gol 6000, Macrogol 6000NF, Glyceryl Monostearate, Linoleic Acid Examples include isopropyl alcohol and liquid paraffin.

[0072] Dispersants include aminoalkyl methacrylate polymer RS, acacia gum, and arabic Agumon powder, carboxyvinyl polymer, sodium carboxymethyl starch, agar Powder, citric acid hydrate, sodium citrate hydrate, glycerin, glycerin fatty acid ester Magnesium silicate, light aluminum oxide, light anhydrous silicic acid, crystalline cellulose, acid Titanium dioxide, sucrose fatty acid ester, stearic acid, magnesium stearate, D-sol Bitol, soy lecithin, low-substituted hydroxypropyl cellulose, dextrin, Corn starch, lactose monohydrate, concentrated glycerin, potato starch, hydroxyethyl Cellulose, hydroxypropyl starch, hydroxypropylcellulose, hypromene Rose, povidone, polyoxyethylene hydrogenated castor oil, polyoxyethylene hydrogenated castor oil 40, Polyoxyethylene hydrogenated castor oil 50, Polyoxyethylene hydrogenated castor oil 60, Resorbate 20, Polysorbate 60, Polysorbate 80, Microcrystalline Macrogol, Macrogol 300, Macrogol 4000, Macrogol 6000, Macrogol 6000NF, anhydrous sodium citrate, magnesium aluminometasilicate, methyl Cellulose, glyceryl monooleate, sorbitan monooleate, monostearin Aluminum phosphate, glyceryl monostearate, sorbitan monostearate, monopal Examples include sorbitan mitinate, sorbitan monolaurate, and sodium lauryl sulfate. ru.

[0073] Antifoaming agents include ethanol, glycerin fatty acid ester, and dimethylpolysiloxane. (For oral use), dimethylpolysiloxane / silicon dioxide mixture, sucrose fatty acid ester, sil Examples include antifoaming agents, silicone oil, sorbitan fatty acid esters, and polysorbate 80. ru.

[0074] Examples of fluidizing agents include hydrated silicon dioxide, light anhydrous silicic acid, and synthetic aluminum silicate. Um, heavy anhydrous silicic acid, aluminum magnesium hydroxide, stearic acid, calcium stearate Cium, magnesium stearate, tricalcium phosphate, talc, aluminum metasilicate Examples include magnesium phosphate and calcium hydrogen phosphate granules.

[0075] Examples of fragrances and scentings include fennel powder, fennel oil, ethyl vanillin, and oleo. Orange, orange extract, orange essence, orange oil, chamomile oil, caramel, d- Camphor, dl-camphor, cinnamon powder, cinnamon oil, citronella oil, sugar flavor Spearmint oil, cherry flavor, clove oil, chili flavor, spearmint tincture, Spruce oil, pine oil, peppermint oil, vanilla flavor, vanillin, bitter essence, Vitabase, cedarwood oil, fruit flavor, Flavor G1, hesperidin pepper - Mint essence, bergamot oil, vermouth flavor, d-borneol, dl -Borneol, matcha, mixed flavor, mint flavor, dl-menthol l-menthol, eucalyptus oil, lavender oil, bonito flakes, bonito flakes powder, lemon powder Examples include dah, lemon oil, rose water, rose oil, and peppermint oil.

[0076] These components may be present individually or in combination of two or more types.

[0077] (Dosage form) The solid composition of this embodiment is, for example, an orally administered preparation (tablet (orally disintegrating tablet, tubular disintegrating tablet, tubular disintegrating tablet)). (Including Abul tablets, effervescent tablets, dispersible tablets, dissolvable tablets, etc.), capsules, granules, and powders, etc.) Preparations for oral application (oral tablets, lozenges, sublingual tablets, buccal tablets, adhesive tablets, gums) This includes, etc. ) and other dosage forms as described in the General Provisions for Preparations of the 18th Revised Japanese Pharmacopoeia, etc. The solid composition of this embodiment is preferably an oral solid composition.

[0078] The dosage forms of the solid composition in this embodiment include, for example, tablets, capsules, pills, granules, and Examples include fine granules. These solid compositions may be sugar-coated or by known methods as needed. It may be coated with a film coating or the like. The dosage form of the solid composition is preferably It is a tablet. Specific examples of tablets include uncoated tablets, film-coated tablets, and sugar-coated tablets. It can be done.

[0079] The solid composition of this embodiment is packaged in bottles, PTP packaging, pouches, sticks, and SPs. They can be packaged and stored airtight. They can also be pillow-wrapped. These may be stored in boxes or the like. The materials used for pillow packaging are not particularly limited. For example, polypropylene film, polyethylene terephthalate film, polyethylene The materials used include resin films such as film, and resin films to which aluminum foil has been attached. It can be placed inside the bottle packaging or pillow packaging if moisture absorption is a concern. It may also be saved internally at the same time.

[0080] The solid composition of this embodiment may be contained in a packaging container to form a package. The solid composition may be contained, for example, in an airtight package. By using a package, For example, it can improve the convenience of using solid compositions. Packaging in this embodiment Specifically, these are pharmaceuticals.

[0081] As for the packaging form of solid dosage forms, the solid composition can be packaged in bottles, PTP packaging (Press Through Packaging). Once packaged, it is packaged in a pouch, stick, or strip package (SP). They may be stored in an airtight container. Furthermore, they may be pillow-wrapped and stored in a box or similar container. Alternatively, from the viewpoint of reducing moisture absorption of the solid composition, a desiccant may be placed inside the bottle packaging, pillow packaging, etc. They may be stored together in the same packaging container.

[0082] Examples of materials used in SP packaging, PTP packaging, stick packaging, pillow packaging, etc. include: For example, polypropylene film, polyethylene terephthalate film, polyethylene film Examples include resin films such as acrylic, and those made by attaching aluminum foil to these resin films. It can be made from either a single-layer film or a multi-layer film (e.g., laminate film). You may use it.

[0083] Furthermore, it is preferable that the materials constituting the packaging container include materials that are less susceptible to the effects of moisture. Such packaging is formed of at least one of a moisture-proof material and a gas barrier material. Examples of packaging include [mention specific packaging].

[0084] For example, PTP (polypropylene) and polyethylene aluminum pillow - A combination of packaging is an example. Also, when the solid composition is a tablet, Considering the suppression of moisture content increase, the storage stability of tablets, and the stability of tablets after opening, as a moisture-proof material Alternatively, PTP packaging (Al-Al packaging) using aluminum on both sides may be used.

[0085] As the gas barrier material, known materials may be used, for example, materials having a functional barrier layer It may also be a laminate film, which serves the same function as the above moisture-proof material, or in combination with the above moisture-proof material. They may be used together.

[0086] Furthermore, packaging containers may be made with environmentally friendly materials. For example, recycled plastics or bio-based materials. Environmentally friendly materials such as mass plastics and biodegradable plastics are used as part of the packaging material or It can be used for all of them.

[0087] (Manufacturing method) In a second embodiment, a process is carried out to mix acetaminophen, glycine, and licorice. A method for producing a solid composition containing a certain amount is provided.

[0088] The production of the solid composition can be carried out using known techniques. Each component can be produced in any step. They are added and finally come into contact with each other. After contact, a solvent and binder are added to the mixture and kneaded together. The resulting mixture may be used as a solid composition.

[0089] The resulting mixture is further subjected to drying and granulation processes to produce granules (granulated material). This is also possible. In this case, granules (granulated materials) containing each component may be prepared separately. Granulation is It can be either wet or dry.

[0090] The resulting granules (granulated material) can be used as is, or the granules can be mixed with additives and then compressed into tablets. The tablets can be molded and manufactured without a protective film, or they can be further coated with a film. .

[0091] For example, when the solid composition is a tablet, the term "tablet" is used in accordance with the "Tablets" section of the General Provisions of the Japanese Pharmacopoeia. It is possible to manufacture the following: Specifically, acetaminophen and / or glycine and licorice. After granulating the mixed powder containing U to obtain granules (granular material), the obtained granules and optionally Tablets may be manufactured by compressing extragranular components into tablets. Alternatively, acetaminophen A mixed powder containing glycine and at least one of licorice is granulated to obtain the first granules. A mixed powder containing acetaminophen, glycine, and at least one of licorice is granulated. A second granule is obtained, and these two types of granules and appropriate extragranule components are compressed into tablets. It may be manufactured. At this time, acetaminophen, glycine, and licorice are used in the first granules. Preferably, it is contained in either the first or second granule. From the viewpoint of increasing the hardness of the solid composition. From this, a mixed powder containing acetaminophen, glycine, and licorice is granulated to produce granules. It is preferable to form granules and include these components in the same granulated material.

[0092] When a solid dosage form contains extragranular components, the granulated granules are treated to form an extragranular component. Tablets may be manufactured by adding ingredients and compressing these mixtures into tablets. The ingredients may be in granular form. For example, acetaminophen, glycine, and licorice. Granulated granules containing the active ingredient are manufactured as the first granules, and granulated granules containing the other active ingredients are manufactured as the second granules. It may be manufactured as follows: In this case, it contains acetaminophen, glycine, and licorice. The first granules and the second granules containing other active ingredients are provided separately, and within the first granules The solid is manufactured so that the active ingredient and the other active ingredients in the second granule do not come into substantial contact. The preparation may be manufactured. Other active ingredients are included in the first granule so that a suitable formulation can be obtained. It may be included in the first granule, or it may be included in the second granule.

[0093] The granules obtained in the above process may be used as is as a granular material.

[0094] Examples are described below to illustrate the present invention in more detail, but the present invention is not limited to these examples. It is not something that should be done. [Examples]

[0095] 1. Raw materials In this example, the following raw materials were used. Note that the licorice extract powder listed below is calculated on a crude drug basis. The ratio is 7:1, meaning it is a 7-fold concentrated form of the crude drug. Furthermore, because glycine has large particle sizes, it is ground using an agate mortar and pestle, and then 100 methicillin is used. It was used after being sifted through a sieve made of ash. [Table 1]

[0096] 2. Manufacturing of granulated products Granules containing glycine, licorice extract powder, or acetaminophen are as follows: It was prepared by adding an appropriate amount of ethanol to each raw material and kneading and granulating using a mortar and pestle. The granulated material was then vacuum-dried and sieved through a 30-mesh sieve to produce the final granules. See Table 2. As shown, the co-formed granules of acetaminophen, glycine, and licorice extract powder are A Cetoaminophen:Glycine:Licorice extract powder in a mass ratio of 1:1:1 (from licorice). The ingredients were blended so that the ratio (in terms of pharmaceutical equivalents) would be 1:7:1.

[0097] 3. Manufacturing of tablets and measurement of their physical properties Weigh each ingredient to a total of 2.5g according to the mixing ratio in Table 2, mix uniformly in a bottle, and compress into tablets. Powders were prepared. The mixing ratios of each component in Table 2 are expressed in parts by mass. Each tablet powder was compressed into 9φ Using a 10.8R punch, a hand press tablet press (manufactured by Riken Seiki) was used to apply a pressure of 1,000 kgf. Tablets containing 300 mg each were prepared by force compression. Note that in Table 2, the components listed as "granules" are... Granules obtained by the method described in "2. Manufacturing of Granules" were added. That is, for example To explain in detail using Examples 1 and 3 described in Table 2, in Example 1, 20 parts by mass of acetaminophen powder, 20 parts by mass of glycine powder, and 20 parts by mass of licorice In contrast to the previous example which used a kiss powder, Example 3 used acetaminophen, glycine, and can Sixty parts by mass of a co-formed granule containing elephant extract powder in a mass ratio of 1:1:1 was used.

[0098] For each tablet, a load cell type tablet hardness tester, Tablet Tester 8M (pha The hardness of the tablets was measured using a rmatron (manufactured by rmatron). Then, the hardness of each tablet from Examples 1 to 3 was measured. For the lock, the wear level after 100 rotations was measured using a wear meter (manufactured by PHARMA TEST). The percentage of the decrease in mass relative to the initial mass was calculated. Furthermore, for each tablet in Examples 1-3, The thickness of the tablets was measured using calipers. The measured values ​​for each measurement are listed in Table 2.

[0099] [Table 2]

[0100] As shown in Table 2, a solid composition containing acetaminophen, glycine, and licorice. It had sufficiently high hardness. Acetaminophen, glycine, and licorice were co-formulated. The solid composition containing the granulated material had particularly high hardness. Furthermore, a solid composition containing acetaminophen, glycine, and licorice has excellent friction properties. It has a certain thickness and consistency, and is made by co-granulating acetaminophen, glycine, and licorice. The solid composition containing the granules exhibited particularly excellent abrasion resistance and tablet thickness.

[0101] Although preferred embodiments and examples of the present invention have been described above, the present invention is not limited to these. This does not mean adding, omitting, substituting, or otherwise modifying the configuration without departing from the spirit of the present invention. It is possible to change this.

Claims

1. A solid composition containing acetaminophen, glycine, and licorice.

2. Claim 1 contains granules comprising acetaminophen, glycine, and licorice. The solid composition described.

3. The solid composition according to claim 1, wherein the hardness of the solid composition is 40 N or more.

4. Claims 1 to include the step of mixing acetaminophen, glycine, and licorice. A method for producing the solid composition described in any one of item 3.

5. A process of forming granules containing acetaminophen, glycine, and licorice, The process of compressing the granules into tablets, A method for producing the solid composition according to claim 4, including the following:

Citation Information

Patent Citations

  • Stable tablet containing crystalline cellulose

    JP2005047861A

  • Solid composition

    JP2024050466A

  • Disintegrating particulate composition containing microfibrous cellulose but not containing excipient

    WO2020022053A1